title: Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients.
authors.forename: Egil S
authors.initials: ES
authors.lastname: Blix
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Irish
authors.forename: Anne
authors.initials: A
authors.lastname: Husebekk
authors.forename: Jan
authors.initials: J
authors.lastname: Delabie
authors.forename: Anne M
authors.initials: AM
authors.lastname: Tierens
authors.forename: June H
authors.initials: JH
authors.lastname: Myklebust
authors.forename: Arne
authors.initials: A
authors.lastname: Kolstad
mesh_terms: D000368:Aged; D019013:CD40 Antigens / Q000378:metabolism*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism* / Q000473:pathology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D051562:Proto-Oncogene Proteins c-bcr / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D019013:CD40 Antigens; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr